Canada falling back on innovation performance, says STIC
Canada’s innovation performance has slumped on most key measures over the past two years, according to a State of the Nation report issued this week by the country’s Science, Technology and Innovation Council.
Canada is now a mid-level player in the global innovation race, passed by rising powers China and South Korea in some categories and falling further behind long-time rivals such as the USA, Germany, Norway and Sweden.
“Data show that some Canadian industries are global leaders,” according to the report, titled State of the Nation 2010. “We are also fortunate to have a strong talent pool that could deliver on high ambitions. The challenge is to deploy talent well, invest in advanced technology, integrate innovation into corporate and country strategies and leverage our efforts to deliver prosperity for all Canadians,” it added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze